Bold thinking. Bolder actions. We are Medtronic. We lead global healthcare technology and boldly attack the most challenging health problems facing humanity by searching out and finding solutions. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 90,000+ passionate people. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second, every hour, every day. Expect more from us as we empower insight-driven care, experiences that put people first, and better outcomes for our world. In everything we do, we are engineering the extraordinary.
Established in 1989, Zahrawi Group is one of the leading and pioneer Healthcare Solutions and Analytical Lab provider in the U.A.E. specialized in Surgical, Medical, Nuclear Medicine, Diagnostic and Analytical Lab. Started in Dubai, U.A.E, Zahrawi Group has an emphatic presence across the GCC with its own operations in the U.A.E, Saudi Arabia, Qatar, Bahrain and Oman. Throughout the years, Zahrawi Group has made its mission to introduce an extensive range of high-quality and advanced technology products to the Middle East market, enabling doctors and patients to access the best in terms of Healthcare. Our portfolio includes more than 200 internationals world-renowned manufacturers including but not limited to Medtronic, Smith & Nephew, Boston Scientific, Hocoma, Johnson & Johnson Vision, Geuder, Linet, Laborie, Polatom, Sirtex, BD, Sysmex, Agilent Technologies, Cepheid, Sakura.
When we challenge, we advance Boston Scientific is dedicated to transforming lives through innovative medical solutions that improve the health of patients around the world. Our work is guided by core values that define Boston Scientific culture and empower our employees. Caring • Meaningful innovation • High performance • Global collaboration • Diversity • Winning spirit
Saluda is transforming patients’ lives with disruptive neural sensing technologies to revolutionize the field of neuromodulation. The Evoke® System, has 10+ years of advanced research, development, & clinical experience, it is the only SmartSCS™ to directly measure the spinal cord’s physiologic response to stimulation using ECAPs to pioneer smart neuromodulation therapy.
SI-BONE, Inc. is a global leading medical device company specializing in Sacropelvic Solutions™. SI-BONE utilizes its iFuse Technology® to develop products to treat degenerative conditions, adult spinal deformity, and pelvic trauma. The iFuse Implant System®, a proprietary minimally invasive surgical implant system to fuse the sacroiliac joint, was launched in 2009 to treat sacroiliac joint dysfunction. The iFuse Implant System portfolio has expanded to include iFuse Bedrock Granite® to provide a solid foundation in spinal deformity surgery, and iFuse TORQ® for treatment of pelvic trauma including sacral fragility and insufficiency fractures.
We’re in relentless pursuit of breakthroughs that change patients’ lives. We innovate every day to make the world a healthier place. It was Charles Pzer’s vision at the beginning and it holds true today. Our unique resources allow us to do more for people. Using our global presence and scale, we’re able to make a dierence in local communities and the world around us. We advance medical innovation and distribute medicines that might not otherwise be available to underserved communities.
Alphamed was set up in 1982 by Dr. Saad F. Al Khayyat the company that was the foundation of Al Khayyat Investments. Al Khayyat Investments is on the threshold of a dynamic new phase of expansion, both domestically and regionally. Our financial position is strong. We have a committed, mature management team who have built on their rich, cumulative experience, gained across numerous geographies, to lead AKI into a position of strength in the UAE and beyond. Our infrastructure is powerful and well developed. Our vision is to retain our leading position in the market and grow further. Al Khayyat Investments trades across eight operating divisions, led by distinguished professionals drawn from a broad spectrum of industries AVANOS Medical is a medical technology company focused on delivering clinically superior medical device solutions that will help patients get back to the things that matter. AVANOS Medical's products are designed to improve patient outcomes and enhance the efficiency of healthcare delivery. The company focuses on three core areas: pain management, airway management, and digestive health. AVANOS Medical's products for digestive health are designed to improve patient comfort and reduce the risk of complications associated with enteral feeding. The company works closely with healthcare providers to ensure that its products meet the needs of patients with different digestive health conditions.
ATREES INTERNATIONAL We are a medical technology, diagnostics, and digital solutions partner. We believe in the power of innovation to improve lives and in the power of technology to support the healthcare sector. We provide the United Arab Emirates healthcare sector with innovative solutions and advanced medical devices in different fields. As a GCC distributor of Metrum Cryoflex, the leading manufacturer of medical devices, we provide the state of art CRYO-S Painless that uses Cryoablation technique for pain management. It is a safe therapeutic method based on the temporary interruption of the sensory functions in selected structures of the nervous system by application of low temperature. Cryoanalgesia is gaining more acceptance as an innovative method in pain relief with a wide range of clinical applications. The CRYO-S Painless has a demonstrated beneﬁcial effect in reducing the dosage or even not requiring opioids for patients in the postoperative period.
We are a young and aggressive company dedicated to becoming a market leader in implementing the latest technologies and medical equipment. We import and market healthcare & Medical Equipments and consumables for hospitals and clinics.
Stratus Medical is a medical device company focused on reducing pain and suffering and improving the quality of life for chronic pain patients through innovation. Our leading technology, the Nimbus Multitined Expandable Electrode was invented by a pain medicine physician who wanted a large volume radiofrequency lesion to reduce the anatomical uncertainty when treating targeted nerves with the goal to provide predictable and sustained pain relief.
Vertos Medical is an interventional pain company committed to developing innovative, minimally invasive treatments for lumbar spinal stenosis (LSS). mild, its proprietary technology, is an image-guided outpatient procedure that removes a major root cause of LSS through an incision smaller than the size of baby aspirin and requires no implants, no general anesthesia, and no stitches. To learn more, visit www.Vertosmed.com.
Established in 2005, Life Medical a leading medical device distributor in the United Arab Emirates. With a head office in Abu Dhabi, we launched our services to support the healthcare with extending products portfolio, identifying opportunities as they emerge and expands to cover the region. we cover 100+ hospitals and medical centers in the UAE, expanding in Oman and other countries in the region. We proudly support hundreds of physicians saving thousands of lives. Our products are supplied around the clock to procedures on daily routine
At Avernus Pharma, we are working together to help patients around the world by changing the way disease is treated. The journey towards solving the big problems that will help people live fuller lives through a personalized treatment approaches. We recognize the unique responsibility we hold to not only provide top-quality care to our customers, but to serve as role models for corporate responsibility and societal advancement for these areas. Positively impacting the lives of our patients and communities along with customer satisfaction at large is not only our promise, but our privilege. Avernus Pharma has managed to support our global partners to expand their business across the GCC with the expertise of talented and specialized teams as well as by avoiding supply chain disruptions and distribution obstacles, ensuring ongoing development of novel treatments for patients. We are confident that, together with our Global partners, we have the right people to achieve our milestones, and more importantly, the milestones of our customers.
High quality therapeutics and diagnostics solutions for patients, ethics as our underlying principle, dedication to innovation and advancement, strong people centricity and environmental sustainability. These five pillars form the foundation of the Menarini Group, an Italian pharmaceutical company with more than 135 years of history. Founded in 1886 in Naples under the name of Farmacia Internazionale, in 1915 Menarini moved to Florence where the Group’s headquarters are still located today. The Menarini Group is present in 140 countries around the world. Its companies span from Europe to Asia, to Africa and the Middle East, to Central America and to the United States where with the acquisition of Stemline Therapeutics, a NASDAQ-listed biopharmaceutical company, the company marked its entry into the US oncology market. Thanks to the valuable contribution of over 17,000 employees, every year more than 500 million packs of drugs are produced at the Group's 18 manufacturing sites including a biotech plant for the manufacturing of monoclonal antibodies that also serves external clients. Our drugs are distributed across 6 continents for the treatment of pathologies in cardiology, oncology, pneumology, inflammation and gastroenterology. Menarini invests in the future and guarantees drug availability in the present for the improvement of patient health and well-being. In its 9 Research & Development centers, Menarini’s main focus is dedicated to therapeutic areas with unresolved pathologies, such as oncology and anti-infectives (AMR), where increasing treatment options is fundamental to helping those in need. The Group's pipeline concentrates on innovative drugs and technologies including both small molecule and biologics for hematologic and solid tumors for greater personalized solutions. The Group has also invested in diagnostics to develop instruments with high speed and precision for diagnoses in various fields such as clinical chemistry, diabetes, immunology, hematology, histology and point-of-care. In addition, Menarini is developing advanced technologies for the analysis of rare tumor cells with single cell precision. From research to manufacturing, from distribution to scientific information, Menarini's goal is to achieve excellence.
Biotronik has 60 years of implantable medical device history and 25 years of automatic, daily & objective remote monitoring experience in the Cardiac Rhythm Management (CRM) space; Biotronik Neuro built upon this technology to bring relief for chronic pain patients with one clear goal: to ensure each patient receives timely and effective post-implant care to continuously confirm their SCS device is optimized as the physician intended.
Mainstay Medical is a medical device company offering a new therapeutic solution for adults suffering from mechanical chronic low back pain (CLBP). ReActiv8 Restorative Neurostimulation is a rehabilitative therapy designed to address impaired neuromuscular control and degeneration of the multifidus muscle linked to mechanical CLBP. ReActiv8 overrides underlying multifidus inhibition by eliciting episodic, isolated contractions which, over time, can facilitate recovery from mechanical CLBP.
Based in Cambridgeshire, UK, with additional offices in Dublin and Pune, Key Pharmaceuticals has been involved in the development, manufacture and regulatory support of generic pharmaceuticals for 20 years. Through our technical knowledge and regulatory expertise, we have successfully developed, registered and launched 22 generic drugs in the UK, with many more in the pipeline. These products are now being prescribed across the country and delivered through our wide distribution network. Our products are used in hospitals, clinics and pharmacies up and down the UK. Through our product and regulatory experience, we are able to provide full support across the product lifecycle to those who require it. Across formulation, development, clinical, manufacturing scale up, registration, ongoing pharmacovigilance support, we will provide you a one stop shop to manage all of these elements. Key Pharmaceuticals is proud to be part of the Lexon Group, which has extensive wholesaling and retail operations within the UK, giving us an unparalleled level of support in serving the UK market.
VIVEX Biologics is a regenerative solutions company improving patient care through the innovation of tissue-based therapies. VIVEX strives to create treatment options and solutions that will improve clinical, surgical, and therapeutic patient outcomes. By leveraging the resources of the nation’s oldest civilian tissue bank, VIVEX focuses on products and new technologies to meet the evolving needs of surgeons and patients while sustaining its over 50-year commitment to serving and honoring tissue donors and families. The company’s portfolio of allograft implants and other signature VIVEX solutions include viable bone matrices; demineralized bone matrices, such as cortical and cancellous bone in strips, sponges, fibers, and putties; amnion grafts; and intervertebral disc tissue allografts.